ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
May 08, 20213P Biopharmaceuticals (3P) and Buzzard Pharmaceuticals (Buzzard) have entered into a partnership agreement for manufacturing of the potent IL-I inhibitor Isunakinra, a recombinant protein for cancer indications. -
3P Biopharmaceuticals Receives FDA approval
September 19, 20193P Biopharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in biologic process development and GMP manufacturing. -
3P Biopharmaceuticals and Nordic Nanovector Extend Partnership
June 26, 2019For further biopharmaceutical development of Betalutin, a non-Hodgkin lymphoma (NHL) treatment.
Pharma Sources Insight January 2025
